WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia

Dec.09.2022
WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia
WNBA star Brittney Griner sentenced to nine years in Russian prison for possession of marijuana in her luggage.

According to Russian authorities, WNBA star Brittney Griner was found with a marijuana electronic pod in her carry-on luggage at a Moscow airport in February of this year. As a result, she has been sentenced to nine years in a Russian prison.


The two-time Olympic basketball champion and member of the US national team was arrested after being found in possession of a container of cannabis derivative oil.


Before announcing the verdict, Griner told the court that she inadvertently brought an electronic cigarette pod containing cannabis oil with her when she flew to Moscow to play basketball in Yekaterinburg in February.


The legality of possessing marijuana products varies by state and jurisdiction, which may impact the experiences of individuals traveling with such products.


In the United States, marijuana remains illegal under federal law.


Although cannabis is legal for adults in some states in the United States, it is still illegal according to federal law. It is not recommended to transport it across borders.


THC is the primary psychoactive substance in marijuana, while CBD is a non-psychoactive component of cannabis that is typically sold in other products such as lotions and supplements.


Certain cannabis-infused products, including CBD oil, are considered illegal at the federal level if they contain more than 0.3% delta-9-tetrahydrocannabinol (THC) by dry weight.


It is currently unclear whether the ammunition canister carried by Griner, as mentioned by Russian officials, contains either one or both of CBD or THC.


In January 2021, the organization reported that the US Food and Drug Administration has only approved one cannabis-derived product, Epidiolex, which contains purified CBD, as well as three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). These can only be obtained with a prescription from a licensed healthcare provider.


TSA Does Not Search for Drugs


Officials from the Transport Safety Management Bureau are required to report suspected illegal activities to local, state, or federal authorities, but they will not conduct searches for illegal drugs during screenings.


According to the website, TSA security personnel do not search for marijuana or other illegal drugs, but if any illegal substance is found during the security screening process, the TSA will report it to law enforcement officials.


The TSA has stated that their dogs cannot detect marijuana. However, in an Instagram post, they reiterated that in the screening process, if a substance or product infused with marijuana is found, even for medical use, law enforcement will be notified.


Carrying marijuana products while traveling abroad.


There are no specific guidelines for traveling internationally with cannabis products, but if a certain product is illegal in a particular country or region, carrying it while traveling could have consequences.


For instance, while marijuana is legal for adults in Canada, the government's tourism website states that transporting these products across the Canadian border, regardless of the amount of medical authorization, is illegal.


According to the website, this applies even if the person is traveling to and from a place where marijuana is decriminalized. The consequences of traveling with cannabis products may include being denied entry into a particular country or region.


According to the Canadian government website, "if you have used cannabis or any substance prohibited by local law in the past, you may be denied entry to your destination country." "You may also be refused entry to other countries in the future.


In recent years, Russia has arrested two women for similar reasons.


In Russia, cannabis for recreational or medicinal purposes is illegal.


In April 2019, an Israeli-American woman was arrested at Moscow airport while traveling from India to Israel and found with 9 grams of cannabis in her luggage, according to BBC News.


A 26-year-old woman, Naama Issachar, was sentenced to more than 7 years in prison for drug trafficking. According to the British Broadcasting Corporation, Russian President Vladimir Putin pardoned her in January 2020 before the visit of then-Israeli Prime Minister Benjamin Netanyahu to Moscow.


According to a report by The Moscow Times in September 2019, a film student from New York was charged with possession of drugs in St. Petersburg for allegedly bringing medical marijuana into the country.


2FIRSTS will continue to track and report on this topic, with updates available on the "2FIRSTS APP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands (TPB) reported third-quarter 2026 Modern Oral net sales of $74.4 million on November 9, up 102.9% year over year and representing 49.2% of consolidated net sales. Total company net sales rose 27.0% to $151.1 million, while net income attributable to TPB declined 81.4% to $3.93 million. The company is expanding the US retail presence of its FRE and ALP nicotine pouch brands and expects its Modern Oral chain-store footprint to grow by more than 70% during 2026. Selling, general and administrative expenses increased 69.1% to $75.3 million, while PMTA-related expenses reached approximately $3.15 million and manufacturing start-up costs totaled about $593,000. ALP plans to open a branded pop-up in New York City's SoHo neighborhood on November 13, alongside a marketing campaign extending into January 2027. TPB owns 50% of ALP but consolidates the venture in its financial statements.
company
Nov.11
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26